X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1060) 1060
Book Review (70) 70
Publication (17) 17
Book Chapter (5) 5
Conference Proceeding (2) 2
Book / eBook (1) 1
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (945) 945
humans (864) 864
cefoxitin - therapeutic use (702) 702
female (577) 577
adult (418) 418
male (406) 406
middle aged (339) 339
cefoxitin (254) 254
aged (241) 241
bacterial infections - drug therapy (211) 211
abridged index medicus (206) 206
anti-bacterial agents - therapeutic use (175) 175
cefoxitin - pharmacology (169) 169
surgical wound infection - prevention & control (168) 168
cefoxitin - administration & dosage (160) 160
adolescent (157) 157
microbial sensitivity tests (152) 152
antibiotics (149) 149
clinical trials as topic (147) 147
prospective studies (146) 146
premedication (145) 145
microbiology (144) 144
infectious diseases (138) 138
cefoxitin - adverse effects (131) 131
random allocation (127) 127
animals (123) 123
pharmacology & pharmacy (120) 120
cephalosporins - therapeutic use (117) 117
anti-bacterial agents - pharmacology (115) 115
pregnancy (98) 98
infections (93) 93
drug therapy, combination (88) 88
drug resistance, microbial (86) 86
drug evaluation (80) 80
double-blind method (79) 79
bacteria (78) 78
child (73) 73
postoperative complications - prevention & control (72) 72
surgery (72) 72
bacterial infections - prevention & control (69) 69
drug therapy, combination - therapeutic use (67) 67
cephamycins - therapeutic use (65) 65
drug resistance (65) 65
bacteria - drug effects (58) 58
bacterial infections - microbiology (58) 58
ampicillin - therapeutic use (56) 56
clindamycin - therapeutic use (56) 56
antibiotic prophylaxis (53) 53
gentamicins - therapeutic use (53) 53
antimicrobial agents (51) 51
cefoxitin - metabolism (51) 51
cesarean section (48) 48
metronidazole - therapeutic use (48) 48
cephalosporins (47) 47
pelvic inflammatory disease - drug therapy (46) 46
time factors (46) 46
ampicillin (45) 45
cefamandole - therapeutic use (44) 44
cefotetan - therapeutic use (44) 44
mice (44) 44
cefotetan (43) 43
child, preschool (43) 43
epidemiology (43) 43
prevalence (42) 42
acute disease (41) 41
cephalosporins - pharmacology (41) 41
hysterectomy (41) 41
infection (41) 41
infant (40) 40
aged, 80 and over (39) 39
cefotaxime - therapeutic use (39) 39
escherichia coli infections - drug therapy (39) 39
urinary tract infections - drug therapy (39) 39
antimicrobial resistance (38) 38
cefazolin - therapeutic use (38) 38
escherichia coli - drug effects (38) 38
kinetics (38) 38
retrospective studies (38) 38
anti-bacterial agents - administration & dosage (37) 37
penicillin (37) 37
risk factors (37) 37
treatment outcome (37) 37
cefoxitin - blood (36) 36
hospitals (36) 36
drug resistance in microorganisms (35) 35
injections, intravenous (34) 34
obstetrics & gynecology (34) 34
biochemical phenomena, metabolism, and nutrition (33) 33
clindamycin (33) 33
penicillins - therapeutic use (33) 33
sulbactam - therapeutic use (33) 33
surgical wound infection - microbiology (33) 33
escherichia coli (32) 32
rats (32) 32
staphylococcus infections (32) 32
bacterial proteins - genetics (31) 31
cefotaxime (31) 31
medicine, general & internal (31) 31
resistance (31) 31
beta-lactamases - metabolism (30) 30
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (888) 888
Japanese (63) 63
Italian (34) 34
German (32) 32
French (22) 22
Spanish (13) 13
Czech (3) 3
Portuguese (3) 3
Bulgarian (2) 2
Chinese (2) 2
Russian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2009, Volume 180, Issue 9, pp. 896 - 902
Rationale: The optimal therapeutic regimen and duration of treatment for Mycobacterium abscessus lung disease is not well established. Objectives: To assess... 
Treatment outcome | Lung diseases | Mycobacterium abscessus | Atypical mycobacteria | lung diseases | DIAGNOSIS | INFECTIONS | NONTUBERCULOUS MYCOBACTERIA | CLARITHROMYCIN RESISTANCE | treatment outcome | CHELONAE | atypical mycobacteria | RAPIDLY GROWING MYCOBACTERIA | IN-VITRO | RESPIRATORY SYSTEM | MULTIDRUG-RESISTANT TUBERCULOSIS | SP-NOV | NODULAR BRONCHIECTASIS | CRITICAL CARE MEDICINE | Sputum - microbiology | Lung - microbiology | Cefoxitin - therapeutic use | Lung Diseases - microbiology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Lung - diagnostic imaging | Lung Diseases - drug therapy | Anti-Bacterial Agents - therapeutic use | Sputum - drug effects | Liver - drug effects | Mycobacterium Infections, Nontuberculous - microbiology | Adult | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Drug Therapy, Combination | Neutropenia - chemically induced | Chemical and Drug Induced Liver Injury - etiology | Doxycycline - adverse effects | Ciprofloxacin - adverse effects | Nontuberculous Mycobacteria - drug effects | Clarithromycin - adverse effects | Doxycycline - therapeutic use | Ciprofloxacin - therapeutic use | Anti-Infective Agents - therapeutic use | Treatment Outcome | Clarithromycin - therapeutic use | Thrombocytopenia - chemically induced | Nontuberculous Mycobacteria - isolation & purification | Amikacin - adverse effects | Amikacin - therapeutic use | Lung - drug effects | Cefoxitin - adverse effects | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2011, Volume 55, Issue 4, pp. 1485 - 1493
Journal Article
JAMA Surgery, ISSN 2168-6254, 05/2016, Volume 151, Issue 5, pp. 432 - 439
Journal Article
Journal Article
Journal Article
Letters in Applied Microbiology, ISSN 0266-8254, 01/2016, Volume 62, Issue 1, pp. 84 - 90
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2012, Volume 56, Issue 3, pp. 1376 - 1381
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
BACTEROIDES-FRAGILIS | IMIPENEM | PHARMACOKINETICS | BACTEREMIA | ERTAPENEM RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | SELECTION | EMERGENCE | KLEBSIELLA-PNEUMONIAE | ENTEROBACTERIACEAE | CEPHALOSPORIN | Conjugation, Genetic | Imipenem - therapeutic use | Cefoxitin - therapeutic use | Carbapenems - administration & dosage | Escherichia coli - drug effects | Humans | Ceftriaxone - pharmacology | Bacterial Load - drug effects | Cefoxitin - pharmacology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Carbapenems - pharmacology | beta-Lactamases - genetics | Ceftriaxone - administration & dosage | Female | Urinary Tract Infections - microbiology | Urinary Bladder - microbiology | beta-Lactamases - metabolism | Disease Models, Animal | Escherichia coli Infections - drug therapy | Imipenem - administration & dosage | Kidney - drug effects | Cefoxitin - administration & dosage | Drug Administration Schedule | Escherichia coli Infections - microbiology | Mutation Rate | Imipenem - pharmacology | Urinary Tract Infections - drug therapy | Kidney - microbiology | beta-Lactams - pharmacology | Animals | Ceftriaxone - therapeutic use | Carbapenems - therapeutic use | Escherichia coli - genetics | Plasmids | Urinary Bladder - drug effects | Anti-Bacterial Agents - pharmacology | Mice | beta-Lactams - therapeutic use | Anti-Bacterial Agents - administration & dosage | beta-Lactams - administration & dosage | Index Medicus | Experimental Therapeutics
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 09/2016, Volume 92, Issue 6, pp. 441 - 446
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 05/2002, Volume 186, Issue 5, pp. 929 - 937
Journal Article
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 07/2017, Volume 17, Issue 1, pp. 483 - 483
Background: Staphylococcus aureus, an important nosocomial pathogen, is frequently associated with infections in human. The management of the infections by it... 
Inducible clindamycin resistance | Nepal | Staphylococcus aureus | MRSA | INFECTIOUS DISEASES | PREVALENCE | Prevalence | Erythromycin - pharmacology | Humans | Middle Aged | Child, Preschool | Infant | Male | Methicillin - pharmacology | Clindamycin - pharmacology | Microbial Sensitivity Tests | Young Adult | Anti-Bacterial Agents - therapeutic use | Aged, 80 and over | Macrolides - pharmacology | Adult | Female | Staphylococcal Infections - microbiology | Drug Resistance, Bacterial - drug effects | Child | Infant, Newborn | Tertiary Care Centers | Cross-Sectional Studies | Staphylococcus aureus - isolation & purification | Methicillin-Resistant Staphylococcus aureus - drug effects | Erythromycin - therapeutic use | Clindamycin - therapeutic use | Cross Infection - microbiology | Adolescent | Aged | Anti-Bacterial Agents - pharmacology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Macrolides - therapeutic use | Staphylococcus aureus - drug effects | Nepal - epidemiology | Methicillin | Drug resistance in microorganisms | Clindamycin | Analysis | Dosage and administration | Research | Prevalence studies (Epidemiology) | Health care | Linezolid | Nosocomial infection | Microbiology | Laboratories | Genes | Clinical isolates | Gram-positive bacteria | Vancomycin | Drug resistance | Incidence | Genotype & phenotype | Antibiotic resistance | Penicillin | Age | Urine | Pathogens | Staphylococcus infections | Antimicrobial agents | Erythromycin | Cefoxitin | Body fluids | Hospitals | Antibiotics | Quality control | Streptogramin B | Index Medicus
Journal Article
BioMed Research International, ISSN 2314-6133, 2018, Volume 2018, pp. 2087693 - 12
Journal Article